CELK AB Stock Nasdaq Stockholm
Equities
SE0009189657
Advanced Medical Equipment & Technology
Sales 2024 * | 2.49B 230M 0 | Sales 2025 * | 2.89B 267M 0 | Capitalization | 3.27B 303M 0 |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.29M - | Net income 2025 * | 131M 12.11M - | EV / Sales 2024 * | 1.86 x |
Net Debt 2024 * | 1.36B 126M 0 | Net Debt 2025 * | 1.67B 154M 0 | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
232
x | P/E ratio 2025 * |
24.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.54% |
Latest transcript on CELK AB
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | Nov. 19 | |
Erik Gatenholm
FOU | Founder | 35 | 15-02-28 |
Director of Finance/CFO | 39 | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
CHM | Chairman | 79 | 22-04-25 |
John Mackay
BRD | Director/Board Member | 62 | 22-12-31 |
Director/Board Member | 68 | 19-12-17 |
1st Jan change | Capi. | |
---|---|---|
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |